2,869
edits
| (One intermediate revision by the same user not shown) | |||
| Line 20: | Line 20: | ||
* '''Acarbose:''' Identified in multiple studies (Harrison 2014, Strong 2016, Harrison 2019), acarbose has been shown to extend lifespan. It is primarily used in the medical field to treat type 2 diabetes by inhibiting enzymes that digest carbohydrates, thereby reducing glucose absorption. | * '''Acarbose:''' Identified in multiple studies (Harrison 2014, Strong 2016, Harrison 2019), acarbose has been shown to extend lifespan. It is primarily used in the medical field to treat type 2 diabetes by inhibiting enzymes that digest carbohydrates, thereby reducing glucose absorption. | ||
* '''Aspirin:''' Aspirin was found to have lifespan-extending properties as reported in Strong 2008. Commonly known for its use as a pain reliever and anti-inflammatory, its role in longevity research adds a new dimension to its therapeutic potential. | * '''Aspirin:''' Aspirin was found to have lifespan-extending properties as reported in Strong 2008. Commonly known for its use as a pain reliever and anti-inflammatory, its role in longevity research adds a new dimension to its therapeutic potential. | ||
* '''Canagliflozin:''' Identified in Miller 2020, canagliflozin is primarily used to treat type 2 diabetes. It works by inhibiting the sodium-glucose transport protein, which helps to reduce blood sugar levels. | * '''Canagliflozin:''' Identified in Miller 2020, canagliflozin is primarily used to treat type 2 diabetes. It works by inhibiting the sodium-glucose transport protein, which helps to reduce blood sugar levels. | ||
* '''Captopril:''' Discovered to increase lifespan in Strong 2022, captopril is typically employed as a treatment for hypertension and certain types of heart failure. | * '''Captopril:''' Discovered to increase lifespan in Strong 2022, captopril is typically employed as a treatment for hypertension and certain types of heart failure. | ||
| Line 37: | Line 35: | ||
* [[Lifespan Extending Compounds in Model Organism]] | * [[Lifespan Extending Compounds in Model Organism]] | ||
* [[2022-04-12 - Dr. Richard Miller - Longevity Supplements - Interventions Testing Program Results]] | * [[2022-04-12 - Dr. Richard Miller - Longevity Supplements - Interventions Testing Program Results]] | ||
* [https://www.lifespan.io/news/prof-richard-miller-on-the-intervention-testing-program/ Interview of Prof. Richard Miller on the Intervention Testing Program (May 5, 2022)] | |||
[[Category:Research]] | [[Category:Research]] | ||